Neuroprotective potential of combination of resveratrol and 4-amino 1,8 naphthalimide in experimental diabetic neuropathy: Focus on functional, sensorimotor and biochemical changes
Authors:
- Shyam S. SharmaSSShyam S. Sharma
- Ashutosh KumarAKAshutosh Kumar
- Manish AroraMAManish Arora
- Ravinder K. KaundalRKRavinder K. Kaundal
- 1 January 2009
- journal article
- Published by Taylor & Francis in Free Radical Research
- Vol. 43 (4) , 400-408
Abstract
The present study investigated whether combination of resveratrol and 4-amino 1,8 naphthalimide (4-ANI) is effective in the development of diabetic neuropathy (DN). After 6 weeks of diabetes induction, rats were treated for 2 weeks with resveratrol and 4-amino 1,8 naphthalimide (4-ANI) either alone or in combination. Experimental end points included functional, behavioural and biochemical parameters along with PAR immunohistochemistry and were performed at the end of treatment. Combination of resveratrol (10 mg/kg) and 4-ANI (3 mg/kg) attenuated conduction and nerve blood flow deficits and resulted in amelioration of diabetic neuropathic pain. Significant reversal of biochemical alterations (peroxynitrite, MDA and NAD levels) were also observed, as well as PAR accumulation in the sciatic nerve. This study suggests the beneficial effect of combining resveratrol and 4-ANI in experimental diabetic neuropathy.Keywords
This publication has 38 references indexed in Scilit:
- Protective effects of 4-amino1,8-napthalimide, a poly (ADP-ribose) polymerase inhibitor in experimental diabetic neuropathyLife Sciences, 2008
- PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathyFree Radical Biology and Medicine, 2008
- Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathyLife Sciences, 2007
- Nicotinamide Reverses Neurological and Neurovascular Deficits in Streptozotocin Diabetic RatsThe Journal of Pharmacology and Experimental Therapeutics, 2007
- EFFECTS OF TROLOX ON NERVE DYSFUNCTION, THERMAL HYPERALGESIA AND OXIDATIVE STRESS IN EXPERIMENTAL DIABETIC NEUROPATHYClinical and Experimental Pharmacology and Physiology, 2006
- Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathyLife Sciences, 2006
- Poly(ADP-Ribose) Polymerase Inhibition Alleviates Experimental Diabetic Sensory NeuropathyDiabetes, 2006
- Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cellsBiochemical and Biophysical Research Communications, 2005
- The Therapeutic Potential of Poly(ADP-Ribose) Polymerase InhibitorsPharmacological Reviews, 2002
- Poly(ADP-ribose) polymerase: a molecular nick-sensorTrends in Biochemical Sciences, 1994